Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for AZETIDIN ABKÖMMLINGE ALS FXR(NR1H4)-MODULIERENDE VERBINDUNGEN
Details for 2020179813
Up to date per 17.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2020179813
Title / Product Name
AZETIDIN ABKÖMMLINGE ALS FXR(NR1H4)-MODULIERENDE VERBINDUNGEN
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2020179813
EP Publication Number
3730487
E-Number
1486876
Language
EN
PCT Number
Publication Date
28.10.2020 A
27.04.2022 B1
Registration Date
27.04.2022
AT Publication Date
15.05.2022
Application Date
09.06.2017
Registration Number
-
Priorities
13.06.2016
US
201662349479 P
IPC
C07D 401/14 20060101AFI20200728BHEP
Maximum Duration of Protection
09.06.2037
Owner
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404
US
Representative
Representative
Haffner und Keschmann Patentanwälte GmbH
Schottengasse 3a
1010 Wien
AT
Inventor
BLOMGREN, Peter A
c/o Gilead Sciences, Inc. 333 Lakeside Drive
Foster City, California 94404
US
CURRIE, Kevin S
c/o Gilead Sciences, Inc. 333 Lakeside Drive
Foster City, California 94404
US
FARAND, Julie
c/o Gilead Sciences, Inc. 333 Lakeside Drive
Foster City, California 94404
US
GEGE, Christian
c/o Phenex Pharmaceuticals AG Donnersbergweg 1
67059 Ludwigshafen
DE
KROPF, Jeffrey E
c/o Gilead Sciences, Inc. 333 Lakeside Drive
Foster City, California 94404
US
XU, Jianjun
c/o Gilead Sciences, Inc. 333 Lakeside Drive
Foster City, California 94404
US
Information about Fees
Click here to load the fees